Exact Mass: 269.1753
Exact Mass Matches: 269.1753
Found 60 metabolites which its exact mass value is equals to given mass value 269.1753,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Orphenadrine
Orphenadrine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. [PubChem]Orphenadrine binds and inhibits both histamine H1 receptors and NMDA receptors. It restores the motor disturbances induced by neuroleptics, in particular the hyperkinesia. The dopamine deficiency in the striatum increases the stimulating effects of the cholinergic system. This stimulation is counteracted by the anticholinergic effect of orphenadrine. It may have a relaxing effect on skeletal muscle spasms and it has a mood elevating effect. D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant CONFIDENCE standard compound; EAWAG_UCHEM_ID 3276
Bifemelane
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System
N-[(1R)-1-(3-Methoxyphenyl)ethyl]-3-phenylpropan-1-amine
Bifemelane
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System
(E,E,E)-2-Methylpropylamide-2,4,12-Tetradecatriene-8,10-diynoic acid|12,13-Didehydro-Anacycline|N-isobutyl-2E,4E,12E-tetradecatrien-8,10-diynamide|Tetradeca-2t,4t,12t-trien-8,10-diinsaeure-isobutylamid|tetradeca-2t,4t,12t-triene-8,10-diynoic acid isobutylamide
(E)-3-(3-Hydroxymethyl-2-butenyl)-7-(3-methyl-2-butenyl)-1H-indole
Pyrrolidide-2,4-Tetradecadiene-8,10-diynoic acid|tetradeca-2E,4E-dien-8,10-diynoic acid pyrrolidide
N,N-dimethyl-2-[(4-methylphenyl)-phenylmethoxy]ethanamine
(8r,9s,13s,14s)-3-amino-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one
(S)-(-)-2,2-BIS(DI-P-TOLYLPHOSPHINO)-1,1-BINAPHTHYL
N,N-di-tert-butyl-6-(methylsulfanyl)-1,3,5-triazine-2,4-diamine
N-(4-ethylphenyl)bicyclo[6.1.0]non-2-ene-9-carboxamide
2-Trimethylsilylamino-4-t-butylamino-6-methoxy-1,3,5-triazine
orphenadrine
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
